Wantao Chen

Title: Innovations of Wantao Chen in Tumor Treatment

Introduction

Wantao Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of tumor treatment through his innovative research and development. His work focuses on the creation of gambogenic acid derivatives, which have shown promising results in enhancing anti-tumor activities.

Latest Patents

Wantao Chen holds a patent for "Gambogenic acid derivatives, preparation method and application thereof." This patent describes gambogenic acid derivatives that possess structures shown as Formula (I) or (II), along with their salts, preparation methods, and applications in tumor treatment. Compared to gambogenic acid, these derivatives exhibit more potent anti-tumor activities, making them a valuable asset in cancer therapy.

Career Highlights

Chen is affiliated with Shanghai Jiao Tong University, where he conducts his research and development. His academic background and expertise have positioned him as a key figure in the field of medicinal chemistry. His innovative approach to drug development has garnered attention and respect within the scientific community.

Collaborations

Some of his notable coworkers include Xu Wang and Zhiyuan Zhang. Their collaborative efforts have contributed to the advancement of research in tumor treatment and the development of effective therapeutic agents.

Conclusion

Wantao Chen's work in developing gambogenic acid derivatives represents a significant advancement in the fight against tumors. His innovative contributions continue to inspire further research and development in the field of cancer treatment.